Skip to main content
Top
Published in: Cancer Chemotherapy and Pharmacology 2/2000

01-01-2000 | ORIGINAL ARTICLE

Impact of the simultaneous administration of the (+)- and (−)-forms of formyl-tetrahydrofolic acid on plasma and intracellular pharmacokinetics of (−)-tetrahydrofolic acid

Authors: Eberhard Schleyer, Karl Lenhard Rudolph, Jan Braess, Michael Unterhalt, Gerhard Ehninger, Wolfgang Hiddemann, Wolfgang Kern

Published in: Cancer Chemotherapy and Pharmacology | Issue 2/2000

Login to get access
Metadata
Title
Impact of the simultaneous administration of the (+)- and (−)-forms of formyl-tetrahydrofolic acid on plasma and intracellular pharmacokinetics of (−)-tetrahydrofolic acid
Authors
Eberhard Schleyer
Karl Lenhard Rudolph
Jan Braess
Michael Unterhalt
Gerhard Ehninger
Wolfgang Hiddemann
Wolfgang Kern
Publication date
01-01-2000
Publisher
Springer-Verlag
Published in
Cancer Chemotherapy and Pharmacology / Issue 2/2000
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s002800050025

Other articles of this Issue 2/2000

Cancer Chemotherapy and Pharmacology 2/2000 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine